Feeds:
Posts
Comments

Archive for the ‘Conference Coverage with Social Media’ Category

Reactions to Original Tweets by @Pharma_BI and by @AVIVA1950 from #BIO2018

Posted in Artificial Intelligence - General, BioTechnology - Venture Creation, BioTechnology - Venture Creation, Venture Capital, Conference Coverage with Social Media on June 12, 2018| Leave a Comment »

Reactions to Original Tweets by @Pharma_BI and by @AVIVA1950 from #BIO2018

Curator: Aviva Lev-Ari, PhD, RN

 

Please review:

  • Re-Tweets and Likes by @Pharma_BI and by @AVIVA1950 from #BIO2018 @IAmBiotech @BIOConvention – BIO 2018, Boston, June 4-7, 2018, BCEC

https://pharmaceuticalintelligence.com/2018/06/11/re-tweets-and-likes-by-pharma_bi-aviva1950-from-bio2018-iambiotech-bioconvention-bio-2018-boston-june-4-7-2018-bcec/

 

  • Original Tweets by @Pharma_BI and by @AVIVA1950 from #BIO2018 @IAmBiotech @BIOConvention – BIO 2018, Boston, June 4-7, 2018, BCEC

https://pharmaceuticalintelligence.com/2018/06/11/original-tweets-by-pharma_bi-and-by-aviva1950-from-bio2018-iambiotech-bioconvention-bio-2018-boston-june-4-7-2018-bcec/

 

  • Thriving at the Survival Calls during Careers in the Digital Age – An AGE like no Other, also known as, DIGITAL

https://pharmaceuticalintelligence.com/2018/06/11/thriving-at-the-survival-calls-during-careers-in-the-digital-age-an-age-like-no-other-also-known-as-digital/

 

     liked a Tweet you were mentioned in

    4h4 hours ago

             

  2.  14h14 hours ago

    More

    0 replies1 retweet2 likes
    Reply

     

    Retweeted

     1

    Liked

     2

    Direct message

  3.  23h23 hours ago

    More

    Gail Thornton Retweeted @pharma_BI

    From Philip K Dick’s obtuse robots to Mark O’Connell’s guide to transhumanism, novelist Julian Gough picks essential reading for a helter skelter world. Can’t wait to read some of the top 10 books. to survive the digital age!

    Gail Thornton added,

    Thriving at the Survival Calls during Careers in the Digital Age – An AGE like no Other, also known as, DIGITAL
    0 replies1 retweet1 like
    Reply

     

    Retweeted

     1

    Liked

     1

    Direct message

  4.  Jun 11

    More

    Original Tweets by and by from   – BIO 2018, Boston, June 4-7, 2018, BCEC

    0 replies1 retweet1 like
    Reply

     

    Retweeted

     1

    Liked

     1

    Direct message

  5.  Jun 11

    More

    Re-Tweets and Likes by from   – BIO 2018, Boston, June 4-7, 2018, BCEC

    0 replies1 retweet1 like
    Reply

     

    Retweeted

     1

    Liked

     1

    Direct message
     liked your Tweet

    Jun 8

    BRAVO  

    In case you missed Gail Thornton‘s Tweet

    Jun 8

    Bill And Melinda Gates Start A Nonprofit Biotech In Boston via  

  10.  Jun 8

    More

    Gail Thornton Retweeted Aviva Lev-Ari

    Gail Thornton added,

    0 replies1 retweet1 like
    Reply

     

    Retweeted

     1

    Liked

     1

    Direct message
     Retweeted your Tweet

    Jun 8

    HEROS for cure   
  12.  liked your Tweets

    Jun 8

    HEROS for cure   

    3 other likes

  13.  Jun 8

    More

    BIO 2018 Makes History in Boston – Attendees, Sessions and Videos highlights via

    0 replies1 retweet1 like
    Reply

     

    Retweeted

     1

    Liked

     1

    Direct message
     liked your Tweet

    Jun 7

     are changing    
     liked your Tweet

    Jun 7

       @FoundationMedicine in 7 days genomic data, clinical data and patient  of patient took place  in    clean data sets are a must  for patient total clinical profile
     liked your Tweet

    Jun 7

    Amazing Conference   
     Retweeted your Tweet

    Jun 7

       
     liked your Tweet

    Jun 7

       

  19.  Jun 7

    More
    Replying to  

    Thanks to Pete Pellerito for keeping the academic zone going . It was great.

     liked your Tweet

    Jun 7

     meets INDUSTRY: BIOTECH & PHARMA with success   
     liked your Tweet

    Jun 7

    BRAVO Scotland in    

  22.  Jun 7

    More
    Replying to   and 2 others

    👊👏🙏

    0 replies1 retweet1 like
    Reply

     

    Retweeted

     1

    Liked

     1

    Direct message
     liked your reply

    Jun 7

      The Greatest   
     liked your Retweet

    Jun 7

    Standing ovation for Ashanthi De Silva at ! “Have hope, be your own advocate, and never give up.” 
  25.  Retweeted your Retweets

    Jun 6

    Our Biocom team has been taking full advantage of making ALL the connections at ! Check us out at the California Pavilion or stop by Startup Stadium tomorrow where we’ll be supporting our member !

    10 other Retweets

     Retweeted a Tweet you are mentioned in

    Jun 6

         
  27.  liked your Tweets

    Jun 6

          for idiopathic fibrosis using  CONNECTION OF DRUG AND DISEASE known after development, pharma needs that BEFORE a drug is developed, clinics based on BRCA for treatment, finding binding targets/drug

    2 other likes

  28.  Retweeted your Tweet

    Jun 6

        COHORT is assisted by  for clinical trials of rare types of cancers on small population of patients. Synthetic data compared with observed data for    can get wrong results by using  

    1 other Retweet

     Retweeted your Tweet

    Jun 6

          for idiopathic fibrosis using  CONNECTION OF DRUG AND DISEASE known after development, pharma needs that BEFORE a drug is developed, clinics based on BRCA for treatment, finding binding targets/drug
  31.  liked your Retweets

    Jun 6

    Are you at ? Be sure to stop by Booth #2101 to learn more about the 10 remarkable Israeli companies, spanning the spectrum of ’s vigorous Life Sciences community- from innovative start-ups to established companies!

    2 other likes

     Retweeted your Retweet

    Jun 6

    Congrats to  for setting the Guinness World Record for largest business partnering event! 
    ,  and  liked your Tweet

    Jun 6

         only by knowing both one can develop applications in    vs   questions are the hard part vs   expertise needed for structural models type of data collected  may not be best 
     and  liked your Tweet

    Jun 6

          for idiopathic fibrosis using  CONNECTION OF DRUG AND DISEASE known after development, pharma needs that BEFORE a drug is developed, clinics based on BRCA for treatment, finding binding targets/drug
     and  liked your Tweet

    Jun 6

         only by knowing both one can develop applications in    vs   questions are the hard part vs   expertise needed for structural models type of data collected  may not be best 
     liked your Tweet

    Jun 6

          for idiopathic fibrosis using  CONNECTION OF DRUG AND DISEASE known after development, pharma needs that BEFORE a drug is developed, clinics based on BRCA for treatment, finding binding targets/drug
     Retweeted your Tweet

    Jun 6

          for idiopathic fibrosis using  CONNECTION OF DRUG AND DISEASE known after development, pharma needs that BEFORE a drug is developed, clinics based on BRCA for treatment, finding binding targets/drug
     liked your Tweet

    Jun 6

       @FoundationMedicine in 7 days genomic data, clinical data and patient  of patient took place  in    clean data sets are a must  for patient total clinical profile
     liked your Tweet

    Jun 5

    @RajuKucherlapati   Detection at pre-natal stages of multiple fetal disorders, abnormality, diagnosis drive treatment – genetic testing critical in cost Cardiomayopaty: in Young athlete genetic disorder     
     and  liked a Tweet you were mentioned in

    Jun 5

    Personalized Medicine & Diagnostics, June 5, 11-12, BIO 2018! Boston, BCEC  via   

    Recent Tweet from Gail Thornton

    Jun 5

    Personalized Medicine & Diagnostics, June 5, 11-12, BIO 2018! Boston, BCEC  via   

  43.  Jun 5

    More

    Personalized Medicine & Diagnostics, June 5, 11-12, BIO 2018! Boston, BCEC via

    Translate Tweet

    0 replies0 retweets2 likes
    Reply

     

    Retweet

     

    Like

     2

    Direct message
  44.  liked Tweets you were included in

    Jun 5

         

    1 other like

  45.  Jun 5

    More

    0 replies1 retweet1 like
    Reply

     

    Retweet

     1

    Like

     1

    Direct message
  46.  liked your Tweets

    Jun 5

    @RajuKucherlapati   Detection at pre-natal stages of multiple fetal disorders, abnormality, diagnosis drive treatment – genetic testing critical in cost Cardiomayopaty: in Young athlete genetic disorder     

    7 other likes

  47.  Jun 5

    More

    0 replies0 retweets1 like
    Reply

     

    Retweet

     

    Like

     1

    Direct message
     liked your Tweet

    Jun 5

    June 4, 2018 –   and , BIO 2018! at Boston BCEC          via 
     Retweeted your Tweet

    Jun 4

     with , MD, President, Novartis Institutes for Biomedical Research (NIBR) !  via 
     Retweeted your reply

    Jun 4

       Novartis Publications #1 collaborator of Pharma-Academia Publish early and Patent late Serial entrepreneur doing research through teams        
     liked your reply

    Jun 4

       Disease areas build the larges  team in the World Killer projects need focus resourced 25 big bets therapeutics lightness RNA splice molecule separating active binders     
     liked your reply

    Jun 4

             finding Drugs? relevant to drug discovery measure phynotype screen relations to molecule – quantify benefits  fatiguability measured  – another tool – data screening optimiz
     liked your reply

    Jun 4

     Vice President, Infectious Diseases & Diagnostics Policy @BIO How DoD can assist Industry to commercialize technologies what coordination in the         
  54.  liked your Tweets

    Jun 4

     (JPM-MCS)          to SKIP a generation        

    1 other like

     liked your Tweet

    Jun 3

    BRAVO MA the  of  
       liked a Tweet you were mentioned in

      5h5 hours ago

               

    3.  12h12 hours ago

      More

      Stanford research sheds light on how species live together via

      https://twitter.com/i/cards/tfw/v1/1006501776340766720?cardname=summary_large_image&autoplay_disabled=true&forward=true&earned=true&edge=true&lang=en&card_height=344&scribe_context=%7B%22client%22%3A%22web%22%2C%22page%22%3A%22connect%22%2C%22section%22%3A%22connect%22%2C%22component%22%3A%22tweet%22%7D&bearer_token=AAAAAAAAAAAAAAAAAAAAAPYXBAAAAAAACLXUNDekMxqa8h%252F40K4moUkGsoc%253DTYfbDKbT3jJPCEVnMYqilB28NHfOPqkca3qaAxGfsyKCs0wRbw#xdm_e=https%3A%2F%2Ftwitter.com&xdm_c=default342&xdm_p=1
      0 replies0 retweets0 likes
      Reply

       

      Retweet

       

      Like

       

      Direct message

    4.  14h14 hours ago

      More

      0 replies1 retweet2 likes
      Reply

       

      Retweeted

       1

      Liked

       2

      Direct message
       liked your reply

      16h16 hours ago

      Congratulations, till 120, please

    6.  24h24 hours ago

      More

      Gail Thornton Retweeted @pharma_BI

      From Philip K Dick’s obtuse robots to Mark O’Connell’s guide to transhumanism, novelist Julian Gough picks essential reading for a helter skelter world. Can’t wait to read some of the top 10 books. to survive the digital age!

      Gail Thornton added,

      Thriving at the Survival Calls during Careers in the Digital Age – An AGE like no Other, also known as, DIGITAL
      0 replies1 retweet1 like
      Reply

       

      Retweeted

       1

      Liked

       1

      Direct message

    7.  Jun 11

      More

      Original Tweets by and by from   – BIO 2018, Boston, June 4-7, 2018, BCEC

      0 replies1 retweet1 like
      Reply

       

      Retweeted

       1

      Liked

       1

      Direct message

    8.  Jun 11

      More

      Re-Tweets and Likes by from   – BIO 2018, Boston, June 4-7, 2018, BCEC

      0 replies1 retweet1 like
      Reply

       

      Retweeted

       1

      Liked

       1

      Direct message
       liked your Tweet

      Jun 8

      BRAVO  

      In case you missed Gail Thornton‘s Tweet

      Jun 8

      Bill And Melinda Gates Start A Nonprofit Biotech In Boston via  

    13.  Jun 8

      More

      Gail Thornton Retweeted Aviva Lev-Ari

      Gail Thornton added,

      0 replies1 retweet1 like
      Reply

       

      Retweeted

       1

      Liked

       1

      Direct message
       Retweeted your Tweet

      Jun 8

      HEROS for cure   
    15.  liked your Tweets

      Jun 8

      HEROS for cure   

      3 other likes

    16.  Jun 8

      More

      BIO 2018 Makes History in Boston – Attendees, Sessions and Videos highlights via

      https://twitter.com/i/cards/tfw/v1/1005057826597883904?cardname=summary&autoplay_disabled=true&forward=true&earned=true&edge=true&lang=en&card_height=130&scribe_context=%7B%22client%22%3A%22web%22%2C%22page%22%3A%22connect%22%2C%22section%22%3A%22connect%22%2C%22component%22%3A%22tweet%22%7D&bearer_token=AAAAAAAAAAAAAAAAAAAAAPYXBAAAAAAACLXUNDekMxqa8h%252F40K4moUkGsoc%253DTYfbDKbT3jJPCEVnMYqilB28NHfOPqkca3qaAxGfsyKCs0wRbw#xdm_e=https%3A%2F%2Ftwitter.com&xdm_c=default344&xdm_p=1
      0 replies1 retweet1 like
      Reply

       

      Retweeted

       1

      Liked

       1

      Direct message
       liked your Tweet

      Jun 7

       are changing    
       liked your Tweet

      Jun 7

         @FoundationMedicine in 7 days genomic data, clinical data and patient  of patient took place  in    clean data sets are a must  for patient total clinical profile
       liked your Tweet

      Jun 7

      Amazing COnference   
       Retweeted your Tweet

      Jun 7

         
       liked your Tweet

      Jun 7

         

    22.  Jun 7

      More
      Replying to  

      Thanks to Pete Pellerito for keeping the academic zone going . It was great.

      0 replies0 retweets0 likes
      Reply

       

      Retweet

       

      Like

       

      Direct message
       liked your Tweet

      Jun 7

       meets INDUSTRY: BIOTECH & PHARMA with success   
       liked your Tweet

      Jun 7

      BRAVO Scotland in    

    25.  Jun 7

      More
      Replying to   and 2 others

      👊👏🙏

      0 replies1 retweet1 like
      Reply

       

      Retweeted

       1

      Liked

       1

      Direct message
       liked your reply

      Jun 7

        The Greatest   
       liked your Retweet

      Jun 7

      Standing ovation for Ashanthi De Silva at ! “Have hope, be your own advocate, and never give up.” 
    28.  Retweeted your Retweets

      Jun 6

      Our Biocom team has been taking full advantage of making ALL the connections at ! Check us out at the California Pavilion or stop by Startup Stadium tomorrow where we’ll be supporting our member !

      10 other Retweets

       Retweeted a Tweet you are mentioned in

      Jun 6

           
    30.  liked your Tweets

      Jun 6

            for idiopathic fibrosis using  CONNECTION OF DRUG AND DISEASE known after development, pharma needs that BEFORE a drug is developed, clinics based on BRCA for treatment, finding binding targets/drug

      2 other likes

    31.  Retweeted your Tweet

      Jun 6

          COHORT is assisted by  for clinical trials of rare types of cancers on small population of patients. Synthetic data compared with observed data for    can get wrong results by using  

      1 other Retweet

       Retweeted your Tweet

      Jun 6

            for idiopathic fibrosis using  CONNECTION OF DRUG AND DISEASE known after development, pharma needs that BEFORE a drug is developed, clinics based on BRCA for treatment, finding binding targets/drug
    34.  liked your Retweets

      Jun 6

      Are you at ? Be sure to stop by Booth #2101 to learn more about the 10 remarkable Israeli companies, spanning the spectrum of ’s vigorous Life Sciences community- from innovative start-ups to established companies!

      2 other likes

       Retweeted your Retweet

      Jun 6

      Congrats to  for setting the Guinness World Record for largest business partnering event! 
      ,  and  liked your Tweet

      Jun 6

           only by knowing both one can develop applications in    vs   questions are the hard part vs   expertise needed for structural models type of data collected  may not be best 
       and  liked your Tweet

      Jun 6

            for idiopathic fibrosis using  CONNECTION OF DRUG AND DISEASE known after development, pharma needs that BEFORE a drug is developed, clinics based on BRCA for treatment, finding binding targets/drug
       and  liked your Tweet

      Jun 6

           only by knowing both one can develop applications in    vs   questions are the hard part vs   expertise needed for structural models type of data collected  may not be best 
       liked your Tweet

      Jun 6

            for idiopathic fibrosis using  CONNECTION OF DRUG AND DISEASE known after development, pharma needs that BEFORE a drug is developed, clinics based on BRCA for treatment, finding binding targets/drug
       Retweeted your Tweet

      Jun 6

            for idiopathic fibrosis using  CONNECTION OF DRUG AND DISEASE known after development, pharma needs that BEFORE a drug is developed, clinics based on BRCA for treatment, finding binding targets/drug
       liked your Tweet

      Jun 6

         @FoundationMedicine in 7 days genomic data, clinical data and patient  of patient took place  in    clean data sets are a must  for patient total clinical profile
       liked your Tweet

      Jun 5

      @RajuKucherlapati   Detection at pre-natal stages of multiple fetal disorders, abnormality, diagnosis drive treatment – genetic testing critical in cost Cardiomayopaty: in Young athlete genetic disorder     
       and  liked a Tweet you were mentioned in

      Jun 5

      Personalized Medicine & Diagnostics, June 5, 11-12, BIO 2018! Boston, BCEC  via   

      Recent Tweet from Gail Thornton

      Jun 5

      Personalized Medicine & Diagnostics, June 5, 11-12, BIO 2018! Boston, BCEC  via   

    46.  Jun 5

      More

      Personalized Medicine & Diagnostics, June 5, 11-12, BIO 2018! Boston, BCEC via

      Translate Tweet

      https://twitter.com/i/cards/tfw/v1/1004087544664018944?cardname=summary&autoplay_disabled=true&forward=true&earned=true&edge=true&lang=en&card_height=130&scribe_context=%7B%22client%22%3A%22web%22%2C%22page%22%3A%22connect%22%2C%22section%22%3A%22connect%22%2C%22component%22%3A%22tweet%22%7D&bearer_token=AAAAAAAAAAAAAAAAAAAAAPYXBAAAAAAACLXUNDekMxqa8h%252F40K4moUkGsoc%253DTYfbDKbT3jJPCEVnMYqilB28NHfOPqkca3qaAxGfsyKCs0wRbw#xdm_e=https%3A%2F%2Ftwitter.com&xdm_c=default345&xdm_p=1
      0 replies0 retweets2 likes
      Reply

       

      Retweet

       

      Like

       2

      Direct message
    47.  liked Tweets you were included in

      Jun 5

           

      1 other like

    48.  Jun 5

      More

      https://twitter.com/i/cards/tfw/v1/1004029288696500224?cardname=summary&autoplay_disabled=true&forward=true&earned=true&edge=true&lang=en&card_height=130&scribe_context=%7B%22client%22%3A%22web%22%2C%22page%22%3A%22connect%22%2C%22section%22%3A%22connect%22%2C%22component%22%3A%22tweet%22%7D&bearer_token=AAAAAAAAAAAAAAAAAAAAAPYXBAAAAAAACLXUNDekMxqa8h%252F40K4moUkGsoc%253DTYfbDKbT3jJPCEVnMYqilB28NHfOPqkca3qaAxGfsyKCs0wRbw#xdm_e=https%3A%2F%2Ftwitter.com&xdm_c=default346&xdm_p=1
      0 replies1 retweet1 like
      Reply

       

      Retweet

       1

      Like

       1

      Direct message
    49.  liked your Tweets

      Jun 5

      @RajuKucherlapati   Detection at pre-natal stages of multiple fetal disorders, abnormality, diagnosis drive treatment – genetic testing critical in cost Cardiomayopaty: in Young athlete genetic disorder     

      7 other likes

    50.  Jun 5

      More

      https://twitter.com/i/cards/tfw/v1/1004013480746340352?cardname=summary&autoplay_disabled=true&forward=true&earned=true&edge=true&lang=en&card_height=130&scribe_context=%7B%22client%22%3A%22web%22%2C%22page%22%3A%22connect%22%2C%22section%22%3A%22connect%22%2C%22component%22%3A%22tweet%22%7D&bearer_token=AAAAAAAAAAAAAAAAAAAAAPYXBAAAAAAACLXUNDekMxqa8h%252F40K4moUkGsoc%253DTYfbDKbT3jJPCEVnMYqilB28NHfOPqkca3qaAxGfsyKCs0wRbw#xdm_e=https%3A%2F%2Ftwitter.com&xdm_c=default347&xdm_p=1
      0 replies0 retweets1 like
      Reply

       

      Retweet

       

      Like

       1

      Direct message
       liked your Tweet

      Jun 5

      June 4, 2018 –   and , BIO 2018! at Boston BCEC          via 
       Retweeted your Tweet

      Jun 4

       with , MD, President, Novartis Institutes for Biomedical Research (NIBR) !  via 
       Retweeted your reply

      Jun 4

         Novartis Publications #1 collaborator of Pharma-Academia Publish early and Patent late Serial entrepreneur doing research through teams        
       liked your reply

      Jun 4

         Disease areas build the larges  team in the World Killer projects need focus resourced 25 big bets therapeutics lightness RNA splice molecule separating active binders     
       liked your reply

      Jun 4

               finding Drugs? relevant to drug discovery measure phynotype screen relations to molecule – quantify benefits  fatiguability measured  – another tool – data screening optimiz
       liked your reply

      Jun 4

       Vice President, Infectious Diseases & Diagnostics Policy @BIO How DoD can assist Industry to commercialize technologies what coordination in the         
    57.  liked your Tweets

      Jun 4

       (JPM-MCS)          to SKIP a generation        

      1 other like

       liked your Tweet

      Jun 3

      BRAVO MA the  of  

Read Full Post »

Original Tweets by @Pharma_BI and by @AVIVA1950 for #BIO2018 @IAmBiotech @BIOConvention – BIO 2018, Boston, June 4-7, 2018, BCEC

Posted in BioTechnology - Venture Creation, BioTechnology - Venture Creation, Venture Capital, Conference Coverage with Social Media on June 11, 2018| Leave a Comment »

Original Tweets by @Pharma_BI and by @AVIVA1950 for #BIO2018 @IAmBiotech @BIOConvention – BIO 2018, Boston, June 4-7, 2018, BCEC

Curator: Aviva Lev-Ari, PhD, RN

 

  1.  Jun 6

    More

    ⁦⁩ ⁦⁩ ⁦⁩ in Cambridge study sensors on patients contact dermatitis patients sensors monitor movement text mining sensation reported by patients with sensors trajectory monitored drug device external partnership

  2.  Jun 6

    More

    ⁦⁩ ⁦⁩ ⁦⁩ new drug: Biotech in Scripps, CA and another in Cambridge, MA and ⁦⁩ as Pharma collaboration with biotech Partnership with UPenn with Duke, NC agility in small co scale in Pharma

  3.  Jun 6

    More

    ⁦⁩ ⁦⁩ ⁦⁩ and Medical community decide on directions for surrogate followed by survival NASH redefine NEW drug innovations will move faster Vaccine for NASH growing obesity population Network for collaboration

  4.  Jun 6

    More

    ⁦⁩ immunicity correlated confirm benefit in based study patient to benefit early on while cost benefit be known later inflammatory indicators across diseases JAKS inhibitors which drug for which patient

  5.  Jun 6

    More

    ⁦⁩ ⁦⁩ ⁦⁩ redefine by genomics clinical trials on patients with Gene expression 150 patients 60% improve rate new drug approved in 2011 in oncology how sustain innovation by cost effective trials? Patient selection

  6.  Jun 6

    More

    ⁦⁩ Mikael Dolsten ⁦⁩ R&D budget for contribution capital allocation focus on deep expertise in multiple drugs in multiple indications Lipitor dependence ends patent expiration

  7.  Jun 6

    More

    only by knowing both one can develop applications in vs questions are the hard part vs expertise needed for structural models type of data collected may not be best

    Like

    3

    View Tweet activity

  8.  Jun 6

    More

  9.  Jun 6

    More

    for idiopathic fibrosis using CONNECTION OF DRUG AND DISEASE known after development, pharma needs that BEFORE a drug is developed, clinics based on BRCA for treatment, finding binding targets/drug

    1 reply2 retweets3 likes
    Reply

    1

    Retweet

    2

    Like

    3

    View Tweet activity

  10.  Jun 6

    More

    for patients goals apply right approach to care right drug respond to therapy is a HC goal combined with patient goals

  11.  Jun 6

    More

    @FoundationMedicine in 7 days genomic data, clinical data and patient of patient took place in clean data sets are a must for patient total clinical profile

    Retweet

    1

    Like

    3

  12.  Jun 6

    More

    COHORT is assisted by for clinical trials of rare types of cancers on small population of patients. Synthetic data compared with observed data for can get wrong results by using

    1 retweet1 like
    Retweet

    1

    Like

    1

  13.  Jun 6

    More

    @FoundationMedicine sequenced 200,000 Cancer patients genome use data to Target positive predicted responders to accelerate clinical trials. use of on genomic data for

  14.  Jun 6

    More

    -based value in leadership is brief the dime

  15.  Jun 6

    More

    #@AVIVA1950 to launch an industry stick initiative

  16.  Jun 6

    More

    2008

  17.  Jun 5

    More

    Breakthrough , June 5, 2018 , Boston, BCEC via

  18.  Jun 5

    More

    -Making and of the : Findings from , June 5, 1:45-2:45PM, BIO 2018!, Boston, BCEC via

  19.  Jun 5

    More

    @KatrineBosley @EditasMedicine Valuation for 23andme? Each pool of capital has different investors been attracted

  20.  Jun 5

    More

    @JohnMaraganore @ALNYLAMPHARMACEUTICALS In 16 years rained $4Billion and expenses $2.5Billion – still not profitable – that what it takes

  21.  Jun 5

    More

    @JeanFrancisFormela Science is extraordinary A lot of capital and very many tech ventures over supply of capital accelerates the business More capital is better, what to invest is critical

  22.  Jun 5

    More

    & , June 5, 11-12, BIO 2018! Boston, BCEC via

  23.  Jun 5

    More

    US is not the only player, CANADA’ universal payer system made major strides lung cancer experienced development of 50 drug base on tumor type predict likelihood drug resistance BR CA patient which not require therapy

  24.  Jun 5

    More

    @RajuKucherlapati Integration of EMR Partners leader missing link is integration of Genomic dat aat the patient level with clinical dat of patients Patients will manage their 23andme data PM is global vs access to care

  25.  Jun 5

    More

    @RajuKucherlapati with million of people with genetic and medical information — searches of profile too group patients for optimal of with DB of – IBM

  26.  Jun 5

    More

    @RajuKucherlapati Detection at pre-natal stages of multiple fetal disorders, abnormality, diagnosis drive treatment – genetic testing critical in cost Cardiomayopaty: in Young athlete genetic disorder

    Like

    2

  27.  Jun 5

    More

    Sajeev Kohli (11th Grade, Waterloo, On, Canada)Receives Top Honor at International BioGENEius Challenge Students from California, Washington and Germany named runners-up June 5, 2018 – Boston, Massachusetts –

  28.  Jun 5

    More

    : based Systems, June 5, BIO 2018!, Boston, BCEC via

    1 like

    Like

    1

  29.  Jun 4

    More

    Tales from the – Four Unique Approaches to Turning into via

  30.  Jun 4

    More

    with , MD, President, Novartis Institutes for Biomedical Research (NIBR) ! via

    1 retweet
    Retweet

    1

  31.  Jun 4

    More

    June 4, 2018 – and , BIO 2018! at Boston BCEC via

    2 likes
    Like

    2

  32.  Jun 4

    More

    @TimothyBelski Joint Program Executive Office for Chemical and Biological Defense Manufacturing for DoD Infrastructure to manage across Government RFP Process

  33.  Jun 3

    More

    We cover this event in Real Time

    1 like

    Like

    1

  34.  Jun 3

    More

    Aviva Lev-Ari Retweeted MassBio

    BRAVO MA the of

    Aviva Lev-Ari added,

    It’s no wonder is in Massachusetts next week. Great things are happening here for the economy and for patients.
    1 like

    Like

    1

  35.  Jun 3

    More

    Aviva Lev-Ari Retweeted JNJ Innovation

    Interested Chief Scientific Officer

    Aviva Lev-Ari added,

    Mark your calendars! Chief Scientific Officer Paul Stoffels will sit down with founder on Monday at 4pm at to discuss how we can speed innovation in science and…

Read Full Post »

Re-Tweets and Likes by @Pharma_BI @AVIVA1950 from #BIO2018 @IAmBiotech @BIOConvention – BIO 2018, Boston, June 4-7, 2018, BCEC

Posted in BioTechnology - Venture Creation, BioTechnology - Venture Creation, Venture Capital, Conference Coverage with Social Media on June 11, 2018| Leave a Comment »

Re-Tweets and Likes by @Pharma_BI and by @AVIVA1950 from #BIO2018 @IAmBiotech @BIOConvention – BIO 2018, Boston, June 4-7, 2018, BCEC

Curator: Aviva Lev-Ari, PhD, RN

 

  1.   Retweeted

     Jun 7

    More

    Aviva Lev-Ari Retweeted Jeff Galvin

    Well put I agree with you, Jeff

    Aviva Lev-Ari added,

    Congratulations for an impactful conference! You brought together the brightest national and international industry minds to advance . I look forward to !
    0 replies1 retweet1 like
    Reply
    Retweeted

    1

    Liked

    1

    View Tweet activity
  2.   Retweeted

     Jun 7

    More

    Aviva Lev-Ari Retweeted I Am Biotech

    For see

    Aviva Lev-Ari added,

    Understanding the Voice: Unique Perspectives on
    0 replies1 retweet1 like
    Reply
    Retweeted

    1

    Liked

    1

    View Tweet activity

  3.  Jun 7

    More

    News Release Makes History in  – , and highlights via

    https://twitter.com/i/cards/tfw/v1/1004938263482847234?cardname=summary&autoplay_disabled=true&forward=true&earned=true&edge=true&lang=en&card_height=130&scribe_context=%7B%22client%22%3A%22web%22%2C%22page%22%3A%22me%22%2C%22section%22%3A%22profile%22%2C%22component%22%3A%22tweet%22%7D&bearer_token=AAAAAAAAAAAAAAAAAAAAAPYXBAAAAAAACLXUNDekMxqa8h%252F40K4moUkGsoc%253DTYfbDKbT3jJPCEVnMYqilB28NHfOPqkca3qaAxGfsyKCs0wRbw#xdm_e=https%3A%2F%2Ftwitter.com&xdm_c=default5891&xdm_p=1
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  4.  Jun 7

    More

    Aviva Lev-Ari Retweeted Christiane Truelove

    BRAVO FDA in 2018 is AGILE

    Aviva Lev-Ari added,

    RT : Under companies have no obligation to honor requests. But some ppl think they do, and exchanges like this could become more common. …
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  5.  Jun 7

    More

    Aviva Lev-Ari Retweeted CCAB

    ASCO weigh in on CAR-Ts versus bispecific antibodies

    Aviva Lev-Ari added,

    Experts at BIO, ASCO weigh in on CAR-Ts versus bispecific antibodies
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  6.  Jun 7

    More

    Aviva Lev-Ari Retweeted Dana-Farber News

    Aviva Lev-Ari added,

    Dana-Farber President and CEO Dr. Laurie Glimcher shares her views on the state of , treatment, and care at .
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity
  7.   Retweeted

     Jun 7

    More

    🇬🇧 has >5600 LifeSci businesses. Find cos w/ solutions for your business in our 🇬🇧 BioPharma asset list

    https://twitter.com/i/cards/tfw/v1/1004763844831563776?cardname=summary_large_image&autoplay_disabled=true&forward=true&earned=true&edge=true&lang=en&card_height=344&scribe_context=%7B%22client%22%3A%22web%22%2C%22page%22%3A%22me%22%2C%22section%22%3A%22profile%22%2C%22component%22%3A%22tweet%22%7D&bearer_token=AAAAAAAAAAAAAAAAAAAAAPYXBAAAAAAACLXUNDekMxqa8h%252F40K4moUkGsoc%253DTYfbDKbT3jJPCEVnMYqilB28NHfOPqkca3qaAxGfsyKCs0wRbw#xdm_e=https%3A%2F%2Ftwitter.com&xdm_c=default5892&xdm_p=1
    0 replies2 retweets3 likes
    Reply
    Retweeted

    2

    Liked

    3

    Direct message

  8.  Jun 7

    More

    Aviva Lev-Ari Retweeted Jim Greenwood

    BRAVO inaugural Henri A. Termeer Biotechnology Visionary Award

    Aviva Lev-Ari added,

    It was my pleasure to present with the inaugural Henri A. Termeer Biotechnology Visionary Award.
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  9.  Jun 7

    More

    Aviva Lev-Ari Retweeted JNJ Innovation

    BRAVO

    Aviva Lev-Ari added,

    LIVE from the session with ‘s who is “looking for communities that are interested about plugging in and being truly ” to foster & to…
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity
  10.   Retweeted

     Jun 7

    More

    The 2018 Bio International Convention has been amazing! This was the view from our water taxi ride to the hotel last night! 🚤🛳🛥⛵️

    0 replies1 retweet1 like
    Reply
    Retweeted

    1

    Liked

    1

    Direct message

  11.  Jun 7

    More

    Aviva Lev-Ari Retweeted Ozmosi

    TRUE

    Aviva Lev-Ari added,

    : Depression, Pain Drug Developers Starve for Dollars as Companies Feast
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity
  12.   Retweeted

     Jun 7

    More

    On this last day of , want to hear from you! What was your favorite part of this year?

    https://twitter.com/i/cards/tfw/v1/1004793829168504833?cardname=poll4choice_text_only&autoplay_disabled=true&forward=true&earned=true&edge=true&lang=en&card_height=184&scribe_context=%7B%22client%22%3A%22web%22%2C%22page%22%3A%22me%22%2C%22section%22%3A%22profile%22%2C%22component%22%3A%22tweet%22%7D&bearer_token=AAAAAAAAAAAAAAAAAAAAAPYXBAAAAAAACLXUNDekMxqa8h%252F40K4moUkGsoc%253DTYfbDKbT3jJPCEVnMYqilB28NHfOPqkca3qaAxGfsyKCs0wRbw#xdm_e=https%3A%2F%2Ftwitter.com&xdm_c=default5893&xdm_p=1
    0 replies2 retweets3 likes
    Reply
    Retweeted

    2

    Like

    3

    Direct message

  13.  Jun 7

    More

    Aviva Lev-Ari Retweeted Sanofi US

    BRAVO Sanofi

    Aviva Lev-Ari added,

    Through Sanofi Ventures, the corporate VC arm of Sanofi, we build strong relationships with innovators and entrepreneurs to develop future strategic collaborations and, ultimately, realize cutting-edge treatments for…
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  14.  Jun 7

    More

    Aviva Lev-Ari Retweeted Sue Desmond-Hellmann

    HEROS for cure

    Aviva Lev-Ari added,

    This quote from the late Henri Termeer explains why I nearly couldn’t finish my 2 minute acceptance speech for the inaugural Henri A. Termeer Biotech Visionary Award without bursting into tears. ⁦⁩
    0 replies1 retweet1 like
    Reply
    Retweet

    1

    Like

    1

    View Tweet activity

  15.  Jun 7

    More

    Aviva Lev-Ari Retweeted BIO Intl Convention

    BRAVO

    Aviva Lev-Ari added,

    That’s a wrap, folks! Thanks to attendees, exhibitors, sponsors, volunteers, staff members, contractors, and for another record breaking year! We really did MAKE HISTORY and…
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  16.  Jun 7

    More

    Aviva Lev-Ari Retweeted Noy Kaufman

    Aviva Lev-Ari added,

    Had such a great time at the  convention in Boston!  Learned so much about entrepreneurship in biotech through the National Science Foundation (NSF) I-CORPS program, Massachusetts Institute of Technology venture mentoring, and UNHInnovation. We co……
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  17.  Jun 7

    More

    Aviva Lev-Ari Retweeted Business Sweden Invest

    Aviva Lev-Ari added,

    Five Swedish hot spots for precision medicine development in Sweden. Find out how you can tap in to the Swedish landscape. Looking for something to bring home from ? Download…
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  18.  Jun 7

    More

    Aviva Lev-Ari Retweeted Alaric DeArment

    Aviva Lev-Ari added,

    You’ve heard about the sky-high response rates, but clinical competence and infrastructure remain two big challenges ahead for therapies. …
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  19.  Jun 7

    More

    Aviva Lev-Ari Retweeted Mike Huckman

    BRAVO

    Aviva Lev-Ari added,

    Here’s on ways to make progress in the fight against opioid addiction. “Buzz Center” via
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  20.  Jun 7

    More

    Aviva Lev-Ari Retweeted JNJ Innovation

    BRAVO

    Aviva Lev-Ari added,

    Congratulations we certainly had a few of those meetings
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  21.  Jun 7

    More

    Aviva Lev-Ari Retweeted Elizabeth Cutler

    Bravo

    Aviva Lev-Ari added,

    If you enjoyed but want more applications for info, come back to Boston in October. Registration is now open:
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  22.  Jun 7

    More

    Aviva Lev-Ari Retweeted Sanofi US

    BRAVO Sanofi, so smart to have bought Genzyme

    Aviva Lev-Ari added,

    Rachel Sha, VP Digital BD & Licensing, during today’s New Tech & Digital Advances for Drug Discovery session: “Big pharma doesn’t typically like to take big risks… We look for partners who are focused on details and…
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  23.  Jun 7

    More

    Aviva Lev-Ari Retweeted Biotech Institute

    BRAVO Challenge!

    Aviva Lev-Ari added,

    This video will “Blow your Mind.” Congratulations, Sajeev Kohli for winning then2018 International Challenge!
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  24.  Jun 7

    More

    Aviva Lev-Ari Retweeted IAM Platform

    Aviva Lev-Ari added,

    IAM Platform Curated Retweet: Via: …
    0 replies1 retweet1 like
    Reply
    Retweet

    1

    Like

    1

    View Tweet activity

  25.  Jun 7

    More

    Aviva Lev-Ari Retweeted Sema4

    and at

    Aviva Lev-Ari added,

    Our CEO Dr Eric Schadt discussing how to extract signal from the noise of sets, using and at
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  26.  Jun 7

    More

    Aviva Lev-Ari Retweeted Worldwide Clinical

    are changing

    Aviva Lev-Ari added,

    Take uncommon pics like this using our giveaway. At Booth 2654, you can meet with our experts & hear how our approach can help your .
    0 replies0 retweets1 like
    Reply
    Retweet

    Like

    1

    View Tweet activity

  27.  Jun 7

    More

    Aviva Lev-Ari Retweeted Lori Collins

    ‘Largest Business Partnering Event’! Proud to cover the event in

    Aviva Lev-Ari added,

    Yesterday, made history by setting a GUINNESS WORLD RECORD for the ‘Largest Business Partnering Event’!  is proud to be a part of
    0 replies0 retweets1 like
    Reply
    Retweet

    Like

    1

    View Tweet activity

  28.  Jun 7

    More

    Aviva Lev-Ari Retweeted Mike Huckman

    BRAVO One HUGE man

    Aviva Lev-Ari added,

    Here’s CEO and Board Chair talking about a big year for his company & at the “Buzz Center” via
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  29.  Jun 7

    More

    Aviva Lev-Ari Retweeted Cleveland Scott York

    45,000 Partening sessions – BRAVO !!

    Aviva Lev-Ari added,

    CSYer Hazel set a world record (with a little help from her friends) by being part of the breaking partnering event that was
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  30.  Jun 7

    More

    Aviva Lev-Ari Retweeted Thermo Fisher G.R.

    BRAVO gravitas

    Aviva Lev-Ari added,

    Congrats & on hosting a wicked great ! That’s a wrap.
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  31.  Jun 7

    More

    Aviva Lev-Ari Retweeted The Global IP Center

    KEY in see our

    Aviva Lev-Ari added,

    🔍
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  32.  Jun 7

    More

    Aviva Lev-Ari Retweeted NHS Research Scotland

    BRAVO Scotland in

    Aviva Lev-Ari added,

    Thank you – building and to help make a positive difference to within , the and internationally – thank you for…
    0 replies0 retweets2 likes
    Reply
    Retweet

    Liked

    2

    View Tweet activity

  33.  Jun 7

    More

    Aviva Lev-Ari Retweeted Quanterix

    BRAVO landscape in in light of

    Aviva Lev-Ari added,

    Great segments from on the landscape in in light of . We’re proud to be among the companies helping to further innovation and achievement in the hub!
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  34.  Jun 7

    More

    Aviva Lev-Ari Retweeted Vanitha Sekar

    made by Bill & Melinda Gates Medical Research Institution most nobel cause

    Aviva Lev-Ari added,

    Fireside chat at with Sue Desmond-Hellmann, Susan Windham-Bannister & Penny Heaton about the Bill & Melinda Gates Medical Research Institution & their aim to translate innovative discoveries into solutions to…
    0 replies0 retweets1 like
    Reply
    Retweet

    Like

    1

    View Tweet activity

  35.  Jun 7

    More

    Aviva Lev-Ari Retweeted HLC

    in Medicine

    Aviva Lev-Ari added,

    RT : See how we’re using tools used in facial recognition to speed up .
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  36.  Jun 7

    More

    Aviva Lev-Ari Retweeted BlueCloud

    BRAVO Argentine

    Aviva Lev-Ari added,

    Our 1st and we had a blast! The experience was so unique and promising. Let’s create a better world, together.
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  37.  Jun 7

    More

    Aviva Lev-Ari Retweeted NFIA North America

    BRAVO Holland! places Holland No. 1 in the world for medical technology patents!

    Aviva Lev-Ari added,

    The ’ world-class and highly collaborative sector places Holland No. 1 in the world for medical technology patents. Learn more about healthcare innovation: …
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  38.  Jun 7

    More

    Aviva Lev-Ari Retweeted Intract Pharma

    Amazing COnference

    Aviva Lev-Ari added,

    Thanks for having us!
    0 replies0 retweets1 like
    Reply
    Retweet

    Like

    1

    View Tweet activity

  39.  Jun 7

    More

    Aviva Lev-Ari Retweeted MacBioCom

    BRAVO

    Aviva Lev-Ari added,

    Fascinating panel discussion this morning and a happy birthday (belated) to
    0 replies0 retweets1 like
    Reply
    Retweet

    Like

    1

    View Tweet activity

  40.  Jun 7

    More

    Aviva Lev-Ari Retweeted Hassan Naqvi

    meets INDUSTRY: BIOTECH & PHARMA with success

    Aviva Lev-Ari added,

    Great seeing so many colleagues great partnering as part of the Academic Zone. See you all in 2019!
    1 reply0 retweets1 like
    Reply

    1

    Retweet

    Like

    1

    View Tweet activity

  41.  Jun 7

    More

    Aviva Lev-Ari Retweeted IN-PART

    INDEED, the best conference I have attended since 2013 when I cover in Real Time conferences as

    Aviva Lev-Ari added,

    And that’s a wrap – what a week for ! Welcome to our new IN-PART’ners & thank you for a great event! (Source: Rene Schwietzke / CC2)
    0 replies0 retweets1 like
    Reply
    Retweet

    Like

    1

    View Tweet activity

  42.  Jun 7

    More

    Aviva Lev-Ari Retweeted JNJ Innovation

    BRAVO J&J for your broad spectrum in

    Aviva Lev-Ari added,

    0:47
    is almost over & what a week it has been! We broke a record, forged new & celebrated 25 years of . Here’s to another 25 years of , & life-changin…
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  43.  Jun 7

    More

    Aviva Lev-Ari Retweeted Penny Heaton

    MOST NOBEL cause by MRI can be a catalyst to address urgent global health

    Aviva Lev-Ari added,

    Enjoyed sharing how the Gates MRI can be a catalyst to address urgent global health challenges in TB, malaria, and diarrheal diseases
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  44.  Jun 7

    More

    Aviva Lev-Ari Retweeted I Am Biotech

    bRAVO I Am Biotech

    Aviva Lev-Ari added,

    , and Future Day: Drives
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity

  45.  Jun 7

    More

    Aviva Lev-Ari Retweeted ARMI

    BRAVO Aussi

    Aviva Lev-Ari added,

    And that’s a wrap. After 4 invigorating days, has been a huge success. A special thank you to for being there & to the Australian delegation including …
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity
  46.   Retweeted

     Jun 7

    More

    Fireside chat with at

    0 replies1 retweet1 like
    Reply
    Retweeted

    1

    Liked

    1

    Direct message
  47.   Retweeted

     Jun 6

    More

    Jeff Galvin, CEO of Rockville-based presented his company’s innovations in therapies for HIV, phenylketonuria, and cancer at . After the presentation, he was mobbed by potential investors and partners!

    2 replies8 retweets14 likes
    Reply

    2

    Retweeted

    8

    Liked

    14

    Direct message
  48.   Retweeted

     Jun 6

    More

    How do you schedule hundreds of meetings all at once? has it figured out. Meeting many great potential supporters.

    0 replies6 retweets7 likes
    Reply
    Retweeted

    6

    Liked

    7

    Direct message
  49.   Retweeted

     Jun 6

    More

    It doesn’t get more epic than this l! The QUEEN, DIANA ROSS!

    0 replies6 retweets25 likes
    Reply
    Retweeted

    6

    Liked

    25

    Direct message
  50.   Retweeted

     Jun 5

    More

    Absolutely inspiring group of advocates on the patient voice panel. I feel honored to be in the room with them, listening to their remarkable stories and insights.

    0 replies6 retweets15 likes
    Reply
    Retweeted

    6

    Liked

    15

    Direct message
  51.   Retweeted

     Jun 6

    More

    Board of Directors Chair on diversity in during his Fireside Chat

    0 replies14 retweets8 likes
    Reply
    Retweeted

    14

    Liked

    8

    Direct message
  52.   Retweeted

     Jun 4

    More

    And for more on-the-ground analysis while you’re at , sign up for our daily newsletter, BIO in 30 Seconds.

    0 replies3 retweets5 likes
    Reply
    Retweeted

    3

    Liked

    5

    Direct message
    Show this thread
  53.   Retweeted

     Jun 4

    More

    THURSDAY: (yes, twice!), 9:00am, 259B, on biotech’s data tsunami

    1 reply1 retweet3 likes
    Reply

    1

    Retweeted

    1

    Liked

    3

    Direct message
    Show this thread
  54.   Retweeted

     Jun 4

    More

    TUESDAY: , 4:15pm, 259A, on a new era of biotech journalism

    1 reply3 retweets5 likes
    Reply

    1

    Retweeted

    3

    Liked

    5

    Direct message
    Show this thread
  55.   Retweeted

     Jun 4

    More

    TUESDAY: , 1:45pm, 210B, on how to apply the lessons of immunotherapy from cancer to other diseases.

    1 reply9 retweets20 likes
    Reply

    1

    Retweeted

    9

    Liked

    20

    Direct message
    Show this thread
  56.   Retweeted

     Jun 4

    More

    MONDAY: , 4:00pm, 210A, talking how to cut waste between big pharma and payers in precision medicine.

    1 reply2 retweets4 likes
    Reply

    1

    Retweeted

    2

    Liked

    4

    Direct message
    Show this thread
  57.   Retweeted

     Jun 4

    More

    MONDAY: , 1:00pm, 206AB, talking what drug hunters look for in early stage assets.

    1 reply1 retweet6 likes
    Reply

    1

    Retweeted

    1

    Liked

    6

    Direct message
    Show this thread
  58.   Retweeted

     Jun 4

    More

    MONDAY: , 12:30pm at , talking best practices for co-working in the life sciences. (From the archives)

    1 reply8 retweets12 likes
    Reply

    1

    Retweeted

    8

    Liked

    12

    Direct message
    Show this thread
  59.   Retweeted

     Jun 4

    More

    THREAD: STAT is all over . Here’s where to find us.

    2 replies10 retweets16 likes
    Reply

    2

    Retweeted

    10

    Liked

    16

    Direct message
    Show this thread
  60.   Retweeted

     Jun 4

    More

    speaking with the member delegation at We’ve come to share with the world the excellence of our life science community in Canada.

    0 replies10 retweets24 likes
    Reply
    Retweeted

    10

    Liked

    24

    Direct message
  61.   Retweeted

     Jun 3

    More

    Team Queensland ready to showcase our state’s fantastic capabilities in all things biotech in Boston

    , ,  and 4 others
    3 replies37 retweets92 likes
    Reply

    3

    Retweeted

    37

    Liked

    92

    Direct message
  62.   Retweeted

     Jun 3

    More

    kicks off tomorrow in Boston, MA. Dr Glenn Begley, CEO and Linda Peterson, COO will be attending. DM us if you would like to connect with them.

    1 reply4 retweets20 likes
    Reply

    1

    Retweeted

    4

    Liked

    20

    Direct message
  63.   Retweeted

     Jun 4

    More

    Heading to my first BIO convention, the rain can’t stop my excitement! 😁

    2 replies7 retweets33 likes
    Reply

    2

    Retweeted

    7

    Liked

    33

    Direct message
  64.   Retweeted

     Jun 4

    More

    Proud to sponsor . We at love supporting and their missions to improve our health! See you at as we keep the startup celebration going tomorrow night! BIOGA25 for $25 GA tix

    , ,  and 3 others
    0 replies11 retweets28 likes
    Reply
    Retweeted

    11

    Liked

    28

    Direct message
  65.   Retweeted

     Jun 1

    More

    Our friends at have put together the ultimate guide to the (). It features a complete list of conferences, private events/receptions, plus much more, all happening throughout the week. Get it here >>

    0 replies4 retweets14 likes
    Reply
    Retweeted

    4

    Liked

    14

    Direct message
  66.   Retweeted

     Jun 6

    More

    Through Pfizer Ventures, we plan to invest $600M in innovative science, with approximately $150M specifically targeted toward neuroscience. Join us at to learn more:

    3 replies26 retweets69 likes
    Reply

    3

    Retweeted

    26

    Liked

    69

    Direct message
  67.   Retweeted

     Jun 4

    More

    “It will take you 10-15 years to get a breakthrough, but if you don’t start, you’ll never get there,” says J&J’s CSO Paul Stoffels when asked about at – at Boston Convention & Exhibition Center

    ,  and 
    0 replies14 retweets31 likes
    Reply
    Retweeted

    14

    Liked

    31

    Direct message
  68.   Retweeted

     Jun 5

    More

    Well done

    2 replies5 retweets31 likes
    Reply

    2

    Retweeted

    5

    Liked

    31

    Direct message
  69.   Retweeted

     Jun 4

    More

    Great Q on driving (innovation in) “Huge opportunity in partnering with Pharma, not in replacing them, mainly due to the complexity of ”

    0 replies10 retweets23 likes
    Reply
    Retweeted

    10

    Liked

    23

    Direct message
  70.   Retweeted

     Jun 1

    More

    Penny Heaton Retweeted BIO Intl Convention

    Looking forward to next week, where we’ll have the opportunity to formally introduce the Gates MRI and share the mission, vision, and values behind the work we’re doing to accelerate product development for diseases that disproportionately affect the world’s poorest.

    Penny Heaton added,

    While you’re still connected to your home or company’s wi-fi, download the myBIO event planning app for ! Browse speakers, sessions, events and exhibitors, and add the ones you want to see to your…
    0 replies17 retweets44 likes
    Reply
    Retweeted

    17

    Liked

    44

    Direct message
  71.   Retweeted

     Jun 4

    More

    Attending ? These SECRET STAIRS, only minutes from the convention center, lead to our local Fort Point restos, breweries and more!

    1 reply8 retweets46 likes
    Reply

    1

    Retweeted

    8

    Liked

    46

    Direct message
  72.   Retweeted

     Jun 1

    More

    I got the numbers on the gender diversity of the speaker roster at , after a packed full of Michaels

    https://twitter.com/i/cards/tfw/v1/1002564069193277440?cardname=summary_large_image&autoplay_disabled=true&forward=true&earned=true&edge=true&lang=en&card_height=344&scribe_context=%7B%22client%22%3A%22web%22%2C%22page%22%3A%22me%22%2C%22section%22%3A%22profile%22%2C%22component%22%3A%22tweet%22%7D&bearer_token=AAAAAAAAAAAAAAAAAAAAAPYXBAAAAAAACLXUNDekMxqa8h%252F40K4moUkGsoc%253DTYfbDKbT3jJPCEVnMYqilB28NHfOPqkca3qaAxGfsyKCs0wRbw#xdm_e=https%3A%2F%2Ftwitter.com&xdm_c=default5894&xdm_p=1
    5 replies23 retweets50 likes
    Reply

    5

    Retweeted

    23

    Like

    50

    Direct message
  73.   Retweeted

     Jun 5

    More

    At … it’s like Epcot in here! So many countries and states courting the bio biz.

    2 replies10 retweets37 likes
    Reply

    2

    Retweeted

    10

    Liked

    37

    Direct message
  74.   Retweeted

     Jun 6

    More

    the best way to conclude this incredible !!!

    1 reply4 retweets20 likes
    Reply

    1

    Retweeted

    4

    Liked

    20

    Direct message
  75.   Retweeted

     Jun 3

    More

    Making History in Boston.

    1 reply19 retweets78 likes
    Reply

    1

    Retweeted

    19

    Liked

    78

    Direct message
  76.   Retweeted

     Jun 4

    More

    At biggest biopharma partnering event in the world, scale is pretty amazing…

    0 replies8 retweets55 likes
    Reply
    Retweeted

    8

    Liked

    55

    Direct message
  77.   Retweeted

     Jun 4

    More

    I can’t believe attendees are told by conference organizers that “locals” recommend: “Let loose and explore the nightlife of Boston, grab a couple beers at the iconic “Cheers” bar.” Let me qualify that: NOBODY IN THIS CITY WOULD RECOMMEND THAT.

    7 replies31 retweets184 likes
    Reply

    7

    Retweeted

    31

    Liked

    184

    Direct message
    Show this thread
  78.   Retweeted

     Jun 5

    More

    How cool is this new tool from ?! It provides info on partnering opportunities and contacts for over 60+ patient advocacy groups. Very useful!

    1 reply16 retweets48 likes
    Reply

    1

    Retweeted

    16

    Liked

    48

    Direct message
  79.   Retweeted

     Jun 4

    More

    And here it is, the most famous Paul Stoffels quote we hear ALL THE TIME at “You take the risk and I take the blame” in

    , ,  and 7 others
    4 replies32 retweets97 likes
    Reply

    4

    Retweeted

    32

    Liked

    97

    Direct message
  80.   Retweeted

     Jun 6

    More

    We MADE GUINNESS HISTORY!

    3 replies53 retweets136 likes
    Reply

    3

    Retweeted

    53

    Liked

    136

    Direct message
  81.   Retweeted

     Jun 6

    More

    . – tonight, Karl-Rudolf Erlemann of was all of us.

    0 replies3 retweets6 likes
    Reply
    Retweeted

    3

    Liked

    6

    Direct message
  82.   Retweeted

     Jun 7

    More

    Which biopharmaceutical companies are making a real difference for patients? Our CSO Michael Severino explains how to spot R&D leaders.

    1 reply6 retweets16 likes
    Reply

    1

    Retweeted

    6

    Liked

    16

    Direct message
  83.   Retweeted

     Jun 6

    More

    Had to get to the front row for the encore at live!

    0 replies3 retweets11 likes
    Reply
    Retweeted

    3

    Liked

    11

    Direct message
  84.   Retweeted

     Jun 7

    More

    There is till time to visit us at , booth 1344. If you require nucleosides and carbohydrates for your business, come to speak to our specialist – maybe we can help.

    0 replies1 retweet1 like
    Reply
    Retweeted

    1

    Liked

    1

    Direct message
  85.   Retweeted

     Jun 7

    More

    Thank you and for helping me meet a real life superhero. Ashanti DeSilva the first person in the world treated with 28 years ago. A passionate , advocate and a personal inspiration

    0 replies4 retweets12 likes
    Reply
    Retweeted

    4

    Liked

    12

    Direct message
  86.   Retweeted

     Jun 7

    More

    .: It’s easy to lose hope when we see headline after headline announcing drug failures, but the reminds us that innovation in Alzheimer’s research is thriving.

    https://twitter.com/i/cards/tfw/v1/1004703521600569345?cardname=summary_large_image&autoplay_disabled=true&forward=true&earned=true&edge=true&lang=en&card_height=344&scribe_context=%7B%22client%22%3A%22web%22%2C%22page%22%3A%22me%22%2C%22section%22%3A%22profile%22%2C%22component%22%3A%22tweet%22%7D&bearer_token=AAAAAAAAAAAAAAAAAAAAAPYXBAAAAAAACLXUNDekMxqa8h%252F40K4moUkGsoc%253DTYfbDKbT3jJPCEVnMYqilB28NHfOPqkca3qaAxGfsyKCs0wRbw#xdm_e=https%3A%2F%2Ftwitter.com&xdm_c=default5895&xdm_p=1
    0 replies2 retweets2 likes
    Reply
    Retweeted

    2

    Liked

    2

    Direct message
  87.   Retweeted

     Jun 6

    More

    Wonderful to meet Baroness Fairhead CBE, Minister of State at DIT on the UK Pavilion at

    , ,  and 6 others
    0 replies4 retweets12 likes
    Reply
    Retweeted

    4

    Liked

    12

    Direct message
  88.   Retweeted

     Jun 7

    More

    The expo floor is a trip around the world of innovation!

    0 replies11 retweets34 likes
    Reply
    Retweeted

    11

    Liked

    34

    Direct message
  89.   Retweeted

     Jun 6

    More

    Great reception at Startup Stadium today. It’s been a great week here in Boston.

    0 replies2 retweets10 likes
    Reply
    Retweeted

    2

    Liked

    10

    Direct message
  90.   Retweeted

     Jun 7

    More

    No rest for attendees! It’s the last day of Convention, but the action isn’t slowing down yet. Look out for these featured events in today’s schedule:

    0 replies5 retweets7 likes
    Reply
    Retweeted

    5

    Liked

    7

    Direct message
  91.   Retweeted

     Jun 7

    More

    It was another history-making ! We look forward to hosting you in on 2019 to make even more history!

    0 replies5 retweets8 likes
    Reply
    Retweeted

    5

    Liked

    8

    Direct message
  92.   Retweeted

     Jun 7

    More

    Pitt has once again surpassed its records for startups in fiscal 2019 with 21 companies spun out of the university. Could a Pitt startup be your next entrepreneurial or investment opportunity?

    0 replies6 retweets12 likes
    Reply
    Retweeted

    6

    Liked

    12

    Direct message
  93.   Retweeted

     Jun 6

    More

    I will survive! ⁦⁩ very Darwinian!

    0 replies2 retweets7 likes
    Reply
    Retweeted

    2

    Liked

    7

    Direct message
  94.   Retweeted

     Jun 7

    More
    Replying to 

    No “jail” means being forced to listen to speak at . I hope he’s wearing cool socks.

    2 replies1 retweet10 likes
    Reply

    2

    Retweeted

    1

    Liked

    10

    Direct message
  95.   Retweeted

     Jun 6

    More

    Don Seiffert Retweeted Suzanne Fraser

    Diana Ross performing “I Will Survive” at the Convention Center for

    Don Seiffert added,

    0:20
    This woman is amazing….actually FABULOUS is a better word. 💃🏾🎶
    0 replies2 retweets15 likes
    Reply
    Retweeted

    2

    Liked

    15

    Direct message
  96.   Retweeted

     Jun 7

    More

    Agendia Retweeted PMC

    Thanks for inviting our CMO, Dr William Audeh, to join this important and timely in Action panel at

    Agendia added,

    “ & Dx Track” has showed progress on several policy fronts. But , , reps say providers are still not incentivized to deliver holistic, value-based…
    1 reply4 retweets9 likes
    Reply

    1

    Retweeted

    4

    Liked

    9

    Direct message
  97.   Retweeted

     Jun 7

    More

    Last day for and last chance to meet 10 companies from and health cluster. Visit us on booth 527, France pavilion.

    , ,  and 6 others
    0 replies11 retweets11 likes
    Reply
    Retweeted

    11

    Liked

    11

    Direct message
  98.   Retweeted

     Jun 7

    More

    Still time to visit us at booth 1753

    , ,  and 3 others
    0 replies5 retweets8 likes
    Reply
    Retweeted

    5

    Liked

    8

    Direct message
  99.   Retweeted

     Jun 7

    More

    Find and meet our BD Manager Emmanuelle Astoul who is attending in Boston to talk about collaboration opportunities with

    0 replies1 retweet2 likes
    Reply
    Retweeted

    1

    Liked

    2

    Direct message
  100.   Retweeted

     Jun 7

    More

    Today last day! Come visit us at booth #1328 and enjoy some argentinian alfajores and coffee!

    0 replies1 retweet2 likes
    Reply
    Retweeted

    1

    Liked

    2

    Direct message
  101.   Retweeted

     Jun 7

    More

    Today at 10:30am, join our Senior Investment Director, Dr. Karen Hong at for “Business Development & Finance: An Investor’s Perspective on Value of New Biotherapeutics” in Room 252AB, Level 2.

    0 replies1 retweet9 likes
    Reply
    Retweeted

    1

    Liked

    9

    Direct message
  102.   Retweeted

     Jun 7

    More

    Fun session y’day at on drug prices, R&D cost, and innovation – many thanks to & ! Good convo abt whether (a) competition will ⬇️ prices in cancer and rare dz, & (b) NIH, prizes, etc. can sustain & focus Rx innovation in the future.

    0 replies2 retweets7 likes
    Reply
    Retweeted

    2

    Liked

    7

    Direct message
  103.   Retweeted

     Jun 7

    More

    Speak to our Team on the UK Pavilion (stand 1333) at the Bio International Convention

    0 replies2 retweets1 like
    Reply
    Retweeted

    2

    Liked

    1

    Direct message
  104.   Retweeted

     Jun 7

    More

    Want to learn more about collaboration between and JPEO-CBRND? Stop by booth 1913 to learn more and how Industry can engage with us.

    0 replies1 retweet1 like
    Reply
    Retweeted

    1

    Liked

    1

    Direct message
  105.   Retweeted

     Jun 7

    More

    Home stretch! Day 4 begins with business development first thing in the morning. .

    0 replies4 retweets12 likes
    Reply
    Retweeted

    4

    Liked

    12

    Direct message
  106.   Retweeted

     Jun 7

    More

    Last day of kicks off with fireside chat in one hour

    0 replies1 retweet3 likes
    Reply
    Retweeted

    1

    Liked

    3

    Direct message
  107.   Retweeted

     Jun 7

    More

    My big takeaway from covering Hong Kong’s quest to build a public biotech market: Everything’s happening crazy fast. Consider yday’s news: -Hua Med applies to list – breaks news on Grail’s listing plans -HK delegation goes on a roadshow at

    https://twitter.com/i/cards/tfw/v1/1004698600570531840?cardname=summary_large_image&autoplay_disabled=true&forward=true&earned=true&edge=true&lang=en&card_height=344&scribe_context=%7B%22client%22%3A%22web%22%2C%22page%22%3A%22me%22%2C%22section%22%3A%22profile%22%2C%22component%22%3A%22tweet%22%7D&bearer_token=AAAAAAAAAAAAAAAAAAAAAPYXBAAAAAAACLXUNDekMxqa8h%252F40K4moUkGsoc%253DTYfbDKbT3jJPCEVnMYqilB28NHfOPqkca3qaAxGfsyKCs0wRbw#xdm_e=https%3A%2F%2Ftwitter.com&xdm_c=default5896&xdm_p=1
    1 reply7 retweets5 likes
    Reply

    1

    Retweeted

    7

    Liked

    5

    Direct message
  108.   Retweeted

     Jun 7

    More

    At Shares the Journey: being an award-winning broadcast journalist and author, and a survivor of breast cancer and myelodysplastic syndrome (MDS),

    0 replies3 retweets9 likes
    Reply
    Retweeted

    3

    Liked

    9

    Direct message
  109.   Retweeted

     Jun 7

    More

    Over the past 21 years, we’ve forged long-term, mutually successful partnerships, bringing innovations and solutions together to meet the worlds healthcare needs. Connect with us at the Scottish Pavillion to discover what we can do for your clinical trial journey.

    0 replies1 retweet4 likes
    Reply
    Retweeted

    1

    Liked

    4

    Direct message
  110.   Retweeted

     Jun 7

    More

    ⁦⁩ hosted a great alumni networking event around

    0 replies1 retweet4 likes
    Reply
    Retweeted

    1

    Liked

    4

    Direct message

  111.  Jun 7

    More

    Thomas Jefferson University announces Global Center in Israel best choice -tech

    https://twitter.com/i/cards/tfw/v1/1004704365599449094?cardname=summary_large_image&autoplay_disabled=true&forward=true&earned=true&edge=true&lang=en&card_height=344&scribe_context=%7B%22client%22%3A%22web%22%2C%22page%22%3A%22me%22%2C%22section%22%3A%22profile%22%2C%22component%22%3A%22tweet%22%7D&bearer_token=AAAAAAAAAAAAAAAAAAAAAPYXBAAAAAAACLXUNDekMxqa8h%252F40K4moUkGsoc%253DTYfbDKbT3jJPCEVnMYqilB28NHfOPqkca3qaAxGfsyKCs0wRbw#xdm_e=https%3A%2F%2Ftwitter.com&xdm_c=default5897&xdm_p=1
    0 replies0 retweets0 likes
    Reply
    Retweet

    Like

    View Tweet activity
  112.   Retweeted

     Jun 6

    More

    Rob Reiner and I will be joining you on stage shortly!

    0 replies8 retweets30 likes
    Reply
    Retweeted

    8

    Liked

    30

    Direct message
  113.   Retweeted

     Jun 5

    More

    Are you at ? Be sure to stop by Booth #2101 to learn more about the 10 remarkable Israeli companies, spanning the spectrum of ’s vigorous Life Sciences community- from innovative start-ups to established companies!

    , ,  and 5 others
    3 replies17 retweets42 likes
    Reply

    3

    Retweeted

    17

    Liked

    42

    Direct message
  114.   Retweeted

     Jun 6

    More

    Great discussion at today’s “Best Practices for Working with Patient Advocacy Organizations,” with our own Jessica Riviere, Senior Director, Biogen

    0 replies7 retweets20 likes
    Reply
    Retweeted

    7

    Liked

    20

    Direct message
  115.   Retweeted

     Jun 6

    More

    We are excited to have , CEO of with us live at the Massachusetts pavilion speaking live

    ,  and 
    0 replies6 retweets19 likes
    Reply
    Retweeted

    6

    Liked

    19

    Direct message
  116.   Retweeted

     Jun 6

    More

    Our President of R&D Akshay Vaishnaw took the stage earlier today at the pavilion to tell our innovation and Massachusetts story. therapeutics

    0 replies8 retweets17 likes
    Reply
    Retweeted

    8

    Liked

    17

    Direct message
  117.   Retweeted

     Jun 5

    More

    Standing ovation for Ashanthi De Silva at ! “Have hope, be your own advocate, and never give up.” – at Boston Convention Center Grand Ballroom

     and 
    0 replies7 retweets18 likes
    Reply
    Retweeted

    7

    Liked

    18

    Direct message
  118.   Retweeted

     Jun 6

    More

    Diversity and inclusion is an BoD priority, an priority and my priority. During my fireside chat w/ Halozyme CEO Helen Torley today at , I committed to not participate in any future panel that is not diverse.

    4 replies15 retweets84 likes
    Reply

    4

    Retweeted

    15

    Liked

    84

    Direct message
  119.   Retweeted

     Jun 5

    More

    Here in Massachusetts, innovation is a way of life. It truly is the . If you want it to happen, you need to be here – Massachusetts is the place where life sciences companies can find the people, the ideas and the resources they need to innovate and grow. – at Boston Convention & Exhibition Center

    , ,  and 
    6 replies52 retweets133 likes
    Reply

    6

    Retweeted

    52

    Liked

    133

    Direct message
  120.   Retweeted

     Jun 6

    More

    We OFFICIALLY made history this week! BIO’s Joanne Duncan accepting our Guinness World Record for ‘Largest Business Parneting Event’

    3 replies25 retweets72 likes
    Reply

    3

    Retweeted

    25

    Liked

    72

    Direct message
  121.   Retweeted

     Jun 6

    More

    Excited to hear member and Reg Affairs Committee member Kelli Tanzella of give her perspective on the regulatory paradigm for NGS panels.

    1 reply4 retweets8 likes
    Reply

    1

    Retweeted

    4

    Liked

    8

    Direct message
    Show this thread
  122.   Retweeted

     Jun 6

    More

    Trailblazing discoveries in health sciences are what we do here.

    0 replies7 retweets8 likes
    Reply
    Retweeted

    7

    Liked

    8

    Direct message
  123.   Retweeted

     Jun 6

    More

    Did you know that every 3.5 minutes someone will die from lung cancer? Boston University and investing in changing this

    0 replies9 retweets6 likes
    Reply
    Retweeted

    9

    Liked

    6

    Direct message
  124.   Retweeted

     Jun 6

    More

    We did it! We set a world record for the Largest Business Partnering Event. Thank you to everyone!

    0 replies6 retweets20 likes
    Reply
    Retweeted

    6

    Liked

    20

    Direct message
  125.   Retweeted

     Jun 6

    More

    I’ve been around the world twice. is the Epcot of Bio, Science & Pharma companies. Proud to see companies recognizing the Making great connections to support our students.

    0 replies5 retweets9 likes
    Reply
    Retweeted

    5

    Liked

    9

    Direct message
  126.   Retweeted

     Jun 6

    More

    Eager to elevate the & voice at this morning’s panel discussion on Communicating Value Through the Eye of the Beholder

    , ,  and 5 others
    2 replies14 retweets49 likes
    Reply

    2

    Retweeted

    14

    Liked

    49

    Direct message
  127.   Retweeted

     Jun 6

    More

    Need for evidence of PM’s value has emerged as “ & Dx Track” theme. Now, , , reps show / parallel review pathway, joint studies by commercial insurers/Dx companies will be key.

    0 replies1 retweet5 likes
    Reply
    Retweeted

    1

    Liked

    5

    Direct message
  128.   Retweeted

     Jun 6

    More

    The winner of Dr. Paul Janssen Award Jim Allison discusses the importance of elevating science to a household conversation if we want to improve our collective health.

    , ,  and 5 others
    0 replies6 retweets9 likes
    Reply
    Retweeted

    6

    Liked

    9

    Direct message
  129.   Retweeted

     Jun 6

    More

    Congrats to for setting the Guinness World Record for largest business partnering event!

    0 replies8 retweets26 likes
    Reply
    Retweeted

    8

    Liked

    26

    Direct message
  130.   Retweeted

     Jun 6

    More

    Diversity and inclusion in science goes beyond who’s at the bench and all the way to who the science serves – 80% of NIH’s genomic data that’s used to push forward precision medicine is from people of European descent. (That’s not okay)

    2 replies10 retweets17 likes
    Reply

    2

    Retweeted

    10

    Liked

    17

    Direct message
  131.   Retweeted

     Jun 6

    More

    speed networking is happening now! Booth #2001

    0 replies4 retweets4 likes
    Reply
    Retweeted

    4

    Liked

    4

    Direct message
  132.   Retweeted

     Jun 6

    More

    Honored to have had the opportunity to address this morning and talk about how real, palpable ultimately means real, palpable patient impact!

    0 replies13 retweets45 likes
    Reply
    Retweeted

    13

    Liked

    45

    Direct message
  133.   Retweeted

     Jun 6

    More

    We don’t do germline editing; society is not at a place to be ready for this, also it’s against recs, says Sandy Macrae . Carrie Wolinetz agrees, says term distinction is crucial, confusing these can feed back into regulatory framework detrimentally.

    0 replies3 retweets5 likes
    Reply
    Retweeted

    3

    Liked

    5

    Direct message
  134.   Retweeted

     Jun 6

    More

    What question would you ask at a discussion about the regulatory framework in human genome editing?

    0 replies2 retweets3 likes
    Reply
    Retweeted

    2

    Liked

    3

    Direct message
  135.   Retweeted

     Jun 6

    More

    “One patient at a time, positive responses are demonstrating that RNAi technology indeed has the potential to bring about a paradigm shift in medicine,” writes Mano Manoharan, SVP, Innovation Chemistry, in a blog post discussing our journey to advance therapeutics.

    https://twitter.com/i/cards/tfw/v1/1004422669507297280?cardname=promo_website&autoplay_disabled=true&forward=true&earned=true&edge=true&lang=en&card_height=271&scribe_context=%7B%22client%22%3A%22web%22%2C%22page%22%3A%22me%22%2C%22section%22%3A%22profile%22%2C%22component%22%3A%22tweet%22%7D&bearer_token=AAAAAAAAAAAAAAAAAAAAAPYXBAAAAAAACLXUNDekMxqa8h%252F40K4moUkGsoc%253DTYfbDKbT3jJPCEVnMYqilB28NHfOPqkca3qaAxGfsyKCs0wRbw#xdm_e=https%3A%2F%2Ftwitter.com&xdm_c=default5898&xdm_p=1
    0 replies3 retweets6 likes
    Reply
    Retweeted

    3

    Liked

    6

    Direct message
  136.   Retweeted

     Jun 6

    More

    The opportunities to advance the clinical trial model with personalized and targeted approaches are endless, from in the

    0 replies7 retweets11 likes
    Reply
    Retweeted

    7

    Liked

    11

    Direct message
  137.   Retweeted

     Jun 6

    More

    Fantastic dialogue going on in 204AB at . Completely candid remarks from tremendous group

    0 replies2 retweets1 like
    Reply
    Retweeted

    2

    Liked

    1

    Direct message
  138.   Retweeted

     Jun 6

    More

    It was great to meet Jim Greenwood, CEO of at . – Robert Naismith, Chairman

    0 replies2 retweets7 likes
    Reply
    Retweeted

    2

    Liked

    7

    Direct message
  139.   Retweeted

     Jun 6

    More

    Wow knows how to put a stellar diverse panel together 🙌

    , ,  and 6 others
    0 replies3 retweets16 likes
    Reply
    Retweeted

    3

    Liked

    16

    Direct message
  140.   Retweeted

     Jun 6

    More

    Front and center, Maryland is in a prime position to move business and innovation forward!

    0 replies5 retweets14 likes
    Reply
    Retweeted

    5

    Liked

    14

    Direct message
  141.   Retweeted

     Jun 6

    More

    This is a loaded panel & plenty of seats avail. Turbo charge R&D activities in 252AB

    0 replies1 retweet4 likes
    Reply
    Retweeted

    1

    Liked

    4

    Direct message
  142.   Retweeted

     Jun 6

    More

    Q to panel as public co CEOs – how do you investor risk? Dahiyat says people will invest if they think co. will make money either way. Hastings says will push some away, draw others in, so do what’s right.

    0 replies1 retweet2 likes
    Reply
    Retweeted

    1

    Liked

    2

    Direct message
  143.   Retweeted

     Jun 6

    More

    Our Biocom team has been taking full advantage of making ALL the connections at ! Check us out at the California Pavilion or stop by Startup Stadium tomorrow where we’ll be supporting our member !

    , ,  and 
    0 replies5 retweets15 likes
    Reply
    Retweeted

    5

    Liked

    15

    Direct message
  144.   Retweeted

     Jun 6

    More

    For those interested in learning more about gene-based therapies, make sure to attend the “Making Genetic Therapies a Reality for Patients” panel featuring our Chief Commercial Officer, Emmanuel Dulac.

    0 replies1 retweet6 likes
    Reply
    Retweeted

    1

    Liked

    6

    Direct message
  145.   Retweeted

     Jun 6

    More

    “ & Dx Track” has showed progress on several policy fronts. But , , reps say providers are still not incentivized to deliver holistic, value-based medicine. Reimbursement paradigms must evolve, they say.

    0 replies1 retweet4 likes
    Reply
    Retweeted

    1

    Liked

    4

    Direct message
  146.   Retweeted

     Jun 6

    More

    Travis McCready from closes out the Possible Talks at in the – “The only way that this industry will evolve, the only way we’ll find cures, is to develop the next generation of diverse talent and to break the mold.” That’s a wrap!

    0 replies17 retweets39 likes
    Reply
    Retweeted

    17

    Liked

    39

    Direct message
  147.   Retweeted

     Jun 6

    More

    “Breakthrough cience occurs when you cross disciplines” Mikael Dolsten

    0 replies1 retweet2 likes
    Reply
    Retweeted

    1

    Liked

    2

    Direct message
  148.   Retweeted

     Jun 6

    More

    🛑! Working on a slide deck to communicate your awesome 🔬? Here are some presentation basic design tips 🎨 for this week’s !

    1 reply2 retweets12 likes
    Reply

    1

    Retweeted

    2

    Liked

    12

    Direct message
    Show this thread
  149.   Retweeted

     Jun 6

    More

    Representatives from European biotech, regulatory and venture capital describe the state of investments in Europe and how global participants can get involved

    0 replies1 retweet1 like
    Reply
    Retweeted

    1

    Liked

    1

    Direct message
  150.   Retweeted

     Jun 6

    More

    Great to meet Australia’s top medical entrepreneurs, discussing how they can take their successful ideas global, creating more jobs and improving patient outcomes

    6 replies6 retweets42 likes
    Reply

    6

    Retweeted

    6

    Liked

    42

    Direct message
  151.   Retweeted

     Jun 6

    More

    Biologos is having a great time at this week in Boston!

    0 replies1 retweet3 likes
    Reply
    Retweeted

    1

    Liked

    3

    Direct message
  152.   Retweeted

     Jun 6

    More

    Great panel at on Digiral Medicines with leaders of of of Marisa Cruz of and Mostafa Kamal of Magellan

    0 replies4 retweets16 likes
    Reply
    Retweeted

    4

    Liked

    16

    Direct message
  153.   Retweeted

     Jun 6

    More

    Great points from re patient consent, consent for life, by Sandy Macrae, and need to ensure patients truly understand what it is they are committing to

    0 replies3 retweets4 likes
    Reply
    Retweeted

    3

    Liked

    4

    Direct message
  154.   Retweeted

     Jun 6

    More

    Q based on diversity training: anybody willing to do training similar to Starbucks? Dahiyat says his company already diverse, but reaches out to area to encourage diversity in science. Johnson says similar program at Dare – get more diversity in science with local youth.

    0 replies1 retweet2 likes
    Reply
    Retweeted

    1

    Liked

    2

    Direct message
  155.   Retweeted

     Jun 6

    More

    Over a 7-year period biotech job growth outpaced national growth by 14% Visit to find out why call home

    0 replies4 retweets5 likes
    Reply
    Retweeted

    4

    Liked

    5

    Direct message
  156.   Retweeted

     Jun 6

    More

    Life sciences companies aren’t innovating processes with and other technologies, but whoever tackles this first will win. from leads a discussion at with leaders from , , , and .

    0 replies3 retweets6 likes
    Reply
    Retweeted

    3

    Liked

    6

    Direct message
  157.   Retweeted

     Jun 6

    More

    🇦🇷 esta presente en la 2018! . . .

    0 replies1 retweet8 likes
    Reply
    Retweeted

    1

    Liked

    8

    Direct message
  158.   Retweeted

     Jun 6

    More

    Independent test results confirm the new VIP ECO upright ultra-low temperature freezer has the lowest total daily energy usage in its class in the industry. Visit us at this week Booth 1927 to learn more. Download your white paper here:

    0 replies2 retweets4 likes
    Reply
    Retweeted

    2

    Liked

    4

    Direct message
  159.   Retweeted

     Jun 6

    More

    DrugDeliveryExperts Retweeted BIO Intl Convention

    And DDE was there… Congrats to !

    DrugDeliveryExperts added,

    We MADE GUINNESS HISTORY!
    0 replies1 retweet2 likes
    Reply
    Retweeted

    1

    Liked

    2

    Direct message
  160.   Retweeted

     Jun 6

    More

    Save the date… reminding everyone at to come visit us next year in !

    0 replies3 retweets8 likes
    Reply
    Retweeted

    3

    Liked

    8

    Direct message
  161.   Retweeted

     Jun 6

    More

    Some impressions representing trends on : , driving the funnel and from all over the world – at Boston Convention & Exhibition Center

    , ,  and 
    0 replies3 retweets12 likes
    Reply
    Retweeted

    3

    Liked

    12

    Direct message
  162.   Retweeted

     Jun 6

    More

    “Europe is a uniquely attractive place for biotech”; lively discussion at our session on Europe’s value proposition for + investment

    0 replies3 retweets6 likes
    Reply
    Retweeted

    3

    Liked

    6

    Direct message
  163.   Retweeted

     Jun 6

    More

    Dahiyat continues: If you are running your business in a way that is profitable, investors won’t care. If not, it doesn’t matter if you’re silent anyway.

    0 replies1 retweet2 likes
    Reply
    Retweeted

    1

    Liked

    2

    Direct message
    Show this thread
  164.   Retweeted

     Jun 6

    More

    Thank you for joining today’s panel with and the and for working with us to bring the patient viewpoint forward in value assessment.

    0 replies2 retweets3 likes
    Reply
    Retweeted

    2

    Liked

    3

    Direct message
  165.   Retweeted

     Jun 6

    More

    Now on stage at former MA governor ; extremely inspiring and a good example that a strong political vision is a key to Life Sciences Cluster development

    0 replies3 retweets10 likes
    Reply
    Retweeted

    3

    Liked

    10

    Direct message
  166.   Retweeted

     Jun 6

    More

    Hats off to — Been coming for most of the last 15 years, and I’ve never seen this level of buzz about business, doing things, in . Congrats on a job well done.

    0 replies9 retweets50 likes
    Reply
    Retweeted

    9

    Liked

    50

    Direct message
  167.   Retweeted

     Jun 6

    More

    Today Paul Stoffels, CSO of will be discussing new strategies for the development of & for the developing world. If you’re at head to Room 251, Level 2 at 3:00pm.

    0 replies6 retweets10 likes
    Reply
    Retweeted

    6

    Liked

    10

    Direct message
  168.   Retweeted

     Jun 6

    More

    Fireside Chat speaker and BIO Board of Directors chair on diversity and business

    0 replies1 retweet5 likes
    Reply
    Retweeted

    1

    Liked

    5

    Direct message
  169.   Retweeted

     Jun 6

    More

    THE is performing LIVE at TONIGHT at the BCEC! You must have a Convention Access badge to enter, and warning: space is extremely limited. Admittance is first-come, first-served, so make sure to arrive early! Thanks to our sponsors

    0 replies3 retweets15 likes
    Reply
    Retweeted

    3

    Liked

    15

    Direct message
  170.   Retweeted

     Jun 5

    More

    WIB Pittsburgh Retweeted Women In Bio

    For those of you at , check this out!

    WIB Pittsburgh added,

    We’re here at Booth #2501! Stop by and chat! Don’t miss out our other events during :
    1 reply5 retweets22 likes
    Reply

    1

    Retweeted

    5

    Liked

    22

    Direct message
  171.   Retweeted

     Jun 2

    More

    Mark your calendars! Chief Scientific Officer Paul Stoffels will sit down with founder on Monday at 4pm at to discuss how we can speed innovation in science and medicine.

    0 replies23 retweets45 likes
    Reply
    Retweeted

    23

    Liked

    45

    Direct message
  172.   Retweeted

     Jun 5

    More

    I believe in dreaming big and focusing small ~ great words to live by. BIOConvention

    ,  and 
    1 reply12 retweets53 likes
    Reply

    1

    Retweeted

    12

    Liked

    53

    Direct message
  173.   Retweeted

     Jun 4

    More

    So much going on today at ! Keynotes from industry leaders, panels on cutting edge research, and 1×1 partnering now happening in the Business Forum!

    0 replies11 retweets33 likes
    Reply
    Retweeted

    11

    Liked

    33

    Direct message
  174.   Retweeted

     Jun 4

    More

    To all who will be attending this week, a very warm welcome to my adopted hometown…AKA “The City of Champions” (in case you’ve forgotten!).

    9 replies19 retweets142 likes
    Reply

    9

    Retweeted

    19

    Liked

    142

    Direct message
  175.   Retweeted

     Jun 2

    More

    It’s no wonder is in Massachusetts next week. Great things are happening here for the economy and for patients.

    https://twitter.com/i/cards/tfw/v1/1002915122543816704?cardname=summary_large_image&autoplay_disabled=true&forward=true&earned=true&edge=true&lang=en&card_height=344&scribe_context=%7B%22client%22%3A%22web%22%2C%22page%22%3A%22me%22%2C%22section%22%3A%22profile%22%2C%22component%22%3A%22tweet%22%7D&bearer_token=AAAAAAAAAAAAAAAAAAAAAPYXBAAAAAAACLXUNDekMxqa8h%252F40K4moUkGsoc%253DTYfbDKbT3jJPCEVnMYqilB28NHfOPqkca3qaAxGfsyKCs0wRbw#xdm_e=https%3A%2F%2Ftwitter.com&xdm_c=default5899&xdm_p=1
    2 replies36 retweets85 likes
    Reply

    2

    Retweeted

    36

    Liked

    85

    Direct message
  176.   Retweeted

     Jun 5

    More

    As an industry, we will continue to champion the evolution of “patients as subjects” to “patients as partners.” They’re the real experts in their conditions. They’re following the research. They’re clinical pioneers. And they’re our real-life inspirations.

    5 replies31 retweets71 likes
    Reply

    5

    Retweeted

    31

    Liked

    71

    Direct message
  177.   Retweeted

     Jun 4

    More

    Enjoyed dinner w/ cool and fun power women Cat Oyler, Suzy Lebold Sue Dillon, Reema Driscoll

    2 replies7 retweets63 likes
    Reply

    2

    Retweeted

    7

    Liked

    63

    Direct message

Read Full Post »

Digital Health Breakthrough Business Models, June 5, 2018 @BIOConvention, Boston, BCEC

Posted in Conference Coverage with Social Media, Digital HealthCare – biotech & internet joint ventures on June 5, 2018| Leave a Comment »

Digital Health Breakthrough Business Models, June 5, 2018 @BIOConvention, Boston, BCEC

Reporter: Aviva Lev-Ari, PhD, RN

 

4:30 PM–5:30 PM Jun 5, 2018 Location: 210C

digitalhealth_icon

Digital Health

Breakthrough Business Models
  • Phynotype and Genotype correlations
Speakers
  • cost and Privacy concerns
  • blockchain application for personal genomic data
  • Super sharing
  • proprietary Analytics

Read Full Post »

Biotechnology Financing, Deal-Making and State of the Industry: Findings from EY Industry Analysis, June 5, 1:45-2:45PM, BIO 2018!, Boston, BCEC

Posted in BioTechnology - Venture Creation, BioTechnology - Venture Creation, Venture Capital, Conference Coverage with Social Media on June 5, 2018| Leave a Comment »

Biotechnology Financing, Deal-Making and State of the Industry: Findings from EY Industry Analysis, June 5, 1:45-2:45PM, BIO 2018!, Boston, BCEC

Reporter: Aviva Lev-Ari, PhD, RN

 

1:45 PM–2:45 PMJun 5, 2018

business_icon

Business Development & Finance

Biotechnology Financing, Deal-Making and State of the Industry: Findings from EY Industry Analysis
Speakers
  • Valuation for 23andme?
  • Each pool of capital has different investors been attracted
  • Science is extraordinary
  • A lot of capital and very many tech ventures
  • over supply of capital accelerates the business
  • More capital is better, understanding in what to invest is critical
  • 2015 greatest year of capital availability
  • Venture (private) capital (US and Europe)
  • Life Sciences M&A – New players and abundant Capital
  • Partnering with investors is critical rounds be bigger and faster
  • In 16 years rained $4Billion and expenses $2.5Billion
  • Orphan Drug for rare disease: Genzyme sold for $18Billion – MS drug
  • Immuno-Oncology: Juno and Kite ~$13Billion
  • New Theory  – came at late stage private company, invest again after iPO then gone
  • Investor’s decision if to invest in early stage or come late??
LOCATION

Room 257AB, Level 2

Read Full Post »

Personalized Medicine & Diagnostics, June 5, 11-12, BIO 2018! Boston, BCEC

Posted in Conference Coverage with Social Media, Personalized and Precision Medicine & Genomic Research on June 5, 2018| Leave a Comment »

Personalized Medicine & Diagnostics, June 5, 11-12, BIO 2018! Boston, BCEC

Reporter: Aviva Lev-Ari, PhD, RN

 

11:00 AM–12:00 PM Jun 5, 2018

personalmedicine

Personalized Medicine & Diagnostics

Precision Medicine Coming of Age with Dr. Raju Kucherlapati, Paul C. Cabot Professor of Genetics and Professor of Medicine, Harvard Medical School
  • Ed Abrams, President PMC – 13% of American are adequately informed on Personalized Medicine. Supporting infrastructure, Scientific and public
Speakers
  • Precision Medicine & Personalized Medicine (PM-PM)
  • cloning gene for CF took 10 years
  • 1990 – Human Genome Program – NIH – sequence the entire Human Genome – for improving disease
  • completed in 2000 at $2.5 Billion cost  – NIH
  • Illumina  – second company to sequence CHinese company will be able to sequence Human Genome for $600
  • Physicians were excited about the Human genome sequencing for PM-PM
  • Millenium , Celera,
  • Genetech –  1998 – Receptin – subset of women Breast Cancer over expression of a gene BR
  • Cancer drug 2001 – Reva – Novartis, CML – only patients with good outocme increased from 30% to 98%
  • Gleevac – is a Blockbuster drug – encouraged development of drugs for rare disease
  • Prevention of Disease  – detect at-risk patients, i.e., CF
  • Meryad Genetics acquired a company that developed technology to detect at-risk in multiple genes not one at a time
  • Amniotic fluid carry fetal DNA — Testing developed to detect fetal disorders
  • Detection at pre-natal stages of multiple fetal disorders, abnormality, diagnosis drive treatment – genetic testing critical in cost containment
  • Cardiomayopaty: in Young athlete genetic disorder, other are related to increased age, 100 genes are involved in right side heart enlargement
  • 10% of Lung Cancer Patients responded to treatment in 2004 – genetic based drug is prescribed only to Patient with EGFR – all positively respond
  • Immune therapies initially in melanoma, improvement in progression pre-survival – if free of Cancer over 5 yeras, patient considered ot be cured
  • Mutation burden measures – drug approved based on probability of positive response
  • Reimbursement – CMS – determineat the National level appproved test in Cancers for reimbursement – it was a challenge
  • Database with million of people with genetic and medical information — searches of profile too group patients for optimal drug matching, integration of EMR with DB of genetics – IBM technologies, Google, Amazon, Microsoft – integrate information
LOCATION

Room 259B, Level 2

Read Full Post »

Press Conference: Exosome-based Drug Delivery Systems, June 5, BIO 2018!, Boston, BCEC

Posted in Conference Coverage with Social Media, Drug Delivery Platform Technology, Exosomes: Natural Carriers for siRNA Delivery on June 5, 2018| Leave a Comment »

Press Conference: Exosome-based Drug Delivery Systems, June 5, BIO 2018!, Boston, BCEC

Reporter: Aviva Lev-Ari, PhD, RN

10:00 AM–11:00 AM Jun 5, 2018 Room 153B

bio2018-mybio-sessionicon-session

Press Conference: Exosome-based Drug Delivery Systems

ALXERION

2007 IDE for Exosome-based drug delivery system in 2018 in Phase III clinical system

In Argentina – Biobank of Exosomes 35,000  sequensed for new drugs in Partnership with MIT

Speakers
  • PI working with Prof. Edelman
NOT Attended
  • DNA samples can be collected for RNA sequences best conditions in lab are needed
  • EXOKIT Cartilege – personalized exosome-based medicines – drug delivery device & system technology for PM
  • High throughput for screening exosomes for genetic drugs,
  • Conflict among species: Fungus and Bacteria – cross communication
  • incubate samples in invitro conditiond as in nature and the Medium has the entire ecosystem – a sample of – basal conditions technologies
  • intra extra viscicles
  • strong discovery and strong delivery
  • In a month – launch of Cancer new drug, lung, use isolated exosome

 

Read Full Post »

Tales from the Translational Frontier – Four Unique Approaches to Turning Novel Biology into Investable Innovations @BIOConvention #BIO2018

Posted in BioTechnology - Venture Creation, BioTechnology - Venture Creation, Venture Capital, Conference Coverage with Social Media, Foundations for supporting Science and Education, Translational Science on June 4, 2018| Leave a Comment »

Tales from the Translational Frontier – Four Unique Approaches to Turning Novel Biology into Investable Innovations @BIOConvention #BIO2018

Reporter: Aviva Lev-Ari, PhD, RN

translationalresearch
Tales from the Translational Frontier – Four Unique Approaches to Turning Novel Biology into Investable Innovations

Translational Research

 2:30 PM–3:45 PM Jun 4, 2018

 Room 206AB, Level 2

Moderator (1)

357755

Speaker (4)

357758

357757

357756

SEE ALL

Who’s Attending (202)

bio2018-mybio-icons-attendees

412311

357940

356138

download

SMS-Oncology_HiRes_C7A7908

0

Esmeralda Megally photo

IMG_3535

DSC_9695

brad

userPhoto

Description

The translational pipeline of medical innovation that flows from academic research centers is at the heart of modern society’s ability to turn the explosion of biological discovery into transformative new medicines. A variety of different models have emerged to overcome the inherent challenges in identifying and advancing biological discoveries to a point where they become investable and can attract private sector partners capable of completing their development, regulatory approval and commercialization. However, most of these models involve academic medical centers, pharma companies and venture investors in the established biotech hubs.
This panel will explore how four distinctive programs that lie outside the flourishing ecosystems of the major biotech centers have been navigating the translational landscape and turning inventions into investable innovations.

Ability Level: All

Session ID: 21200

Tags
Interest AreaTranslational Research
Session TracksTranslational Research
Session TypesBreakout Sessions
Session TypesAll
Session TypesInteractive Panel
Session TypesInteractive Panel

Read Full Post »

Fireside Chat with James (Jay) Bradner, MD, President, Novartis Institutes for Biomedical Research (NIBR) @BIO2018!

Posted in Conference Coverage with Social Media on June 4, 2018| Leave a Comment »

Fireside Chat with James (Jay) Bradner, MD, President, Novartis Institutes for Biomedical Research (NIBR)

Reporter: Aviva Lev-Ari, PhD, RN

 

  • Novartis Publications show vast collaborations with Academia, #1 collaborator of Biotech/Pharma and Academia
  • Publish early and Patent late
  • Social experience, Serial entrepreneur doing research through teams
  • Legendary Disease areas build the larges #chemicalbiology team in the World Killer projects need focus resourced 25 big bets therapeutics lightness RNA splice molecule form rig=dges separating active binders from therapeutic binders small molecule biophysics What drugable means?
  • Computational look up table created with UC Berkeley reactive cyctine mapped
  • #ML finding Drugs? relevant to drug discovery
  • measure phynotype screen relations to molecule – quantify benefits
  • @MIT fatiguability measured
  • #ML – another tool – data screening optimization,

 

Read Full Post »

June 4, 2018 – Department of Defense Medical Innovation and Biodefense Forum, BIO 2018! at Boston Convention & Exhibition Center

Posted in Bio Instrumentation in Experimental Life Sciences Research, Bioengineering & reverse engineering design, Biological Engineering, Biomarkers & Medical Diagnostics, Biomedical Measurement Science, BioTechnology - Venture Creation, Conference Coverage with Social Media on June 4, 2018| Leave a Comment »

June 4, 2018 – Department of Defense Medical Innovation and Biodefense Forum, BIO 2018! at Boston Convention & Exhibition Center

Announcement

Aviva Lev-Ari, PhD, RN,

https://mybio.org/profile/member/2029564?profile_tabs=profile

Founder and Director of LPBI Group will be in attendance covering the event in REAL TIME

https://pharmaceuticalintelligence.com/2018/05/26/bio-2018-june-4-7-2018-at-boston-convention-exhibition-center/

@pharma_BI

@AVIVA1950

for

#BIO2018

@BIOConvention

9:00 AM–12:00 PM Jun 4, 2018

bio2018-mybio-sessionicon-session
Department of Defense Medical Innovation and Biodefense Forum
Speakers
  • How DoD can assist Industry to commercialize technologies
  • How the coordination in the Infectious disease takes place
  • Manufacturing for DoD
  • Infrastructure to manage across Government RFP Process
  • Devices requires detailed engineering for use in Field hospitals
  • Regulatory, Scheduling and Engineering problems
  • Development is for all the Forces of the US and for all the Forces of US Allies — design for CIvilian first respnders as well
  • Some partners are commercial Partners, they need to approach DoD with novel product concept
  • FDA approved vs Right to Try – DoD uses both
  • Small business Program, success in bringing product to market
  • 20 years ago: Communities of interest – 20 orgs community common goals in Health Care, rehabilitation after coming home,
  • MROC – Conference in Florida DoD to explain the Public the process of engagement with Do
  • Interagency partnership
  • DoD starts with good ideas, concept studies – innovators
  • Collaborations with Academia, we are available to be approached
  • DoD will partner with small businesses to avoid the Regulatory process  – to save time and resources in the commercialization process
  • How a civilian concept FITS the needs of DoD
  • Sustaining an innovation along the years
  • Need for small business to approach DoD to make the contact
  • Where is a small business in the Development cycle? DoD can help calibrate
  • A System of Systems: Diagnostics drive decisions
  • develop partnerships in consortia
  • Six month to vaccinate 17,000 with a Vaccine for EBOLA
  • DoD of respective countries are collaborating with US DoD
  • Threat environment changes over time vs modify known threats
  • Monoclonal antibody – the Industry developed the manufacturing technology and DoD is user of Industry products
  • All research for the Joint Force, Chemical, Biological,
  • Short time to market solutions are of interest for DoD to identify
  • Military relevance: Key for funding
  • Announcements of DoD on WHAT PROBLEMS DoD tries to solve
  • DoD and HHS — aligned for common solution to avoid redundancy
  • Development of profilaxix is very expensive, DoD budget has competing goals: Next soldier suit,
  • FDA and DoD need to collaborate for DoDs needs
  • Order transaction authority,
  • Congress set aside a budget for small businesses to use accounting systems for Small business to interact with DoD
  • How to get a digital signal to the brain: Expertise in many disciplines: EE, Ethomology
  • Delivery, test , evaluation, develop sensors, IS to manage threats, Diagnostics,
  • How to do Business with Industry?
  • Congress asked for a Consorsium to engage with Industry in a different form than we engaged before
  • Partnerships for out of the box thinking and going quickly – the appetite for is greater then evr before
  • Successful area: Diagnostics – adoptation of existing diagnostics for military applications
  • Platform technologies: Metabolic, Vaccines,
  • Leverage existing technologies to solve DoD concerns
  • involved with MCS help Government to learn how to build their Office
  • Genomic, Proteomics, therapeutics candidates, Prophylaxis as Vaccines
  • In the event of an outbreak: clinicians, 1st responders
Panel 2: Clay Holloway, Director of Strategic Initiatives, Joint Project Manager, Medical Countermeasure Systems (JPM-MCS)
  • Partnering is key
  • capability requirements: broad spectrum capabilities
  • Decision tools to be used at studies for data analysis for decision making
  • Risks in partnership: DoD needs to evaluate ideas for next generation to SKIP one generation
  • How to used different agreement strategically? Streamline DoD Methods
  • Have continuous access to assets

 

LOCATION

Room 205ABC, Level 2

Read Full Post »

« Newer Posts - Older Posts »